Mostrando 2 resultados de: 2
Filtros aplicados
Subtipo de publicación
Article(2)
Safety, immunogenicity and preliminary efficacy of multiple-site vaccination with an Epidermal Growth Factor (EGF) based cancer vaccine in advanced non small cell lung cancer (NSCLC) patients
ArticleAbstract: The prognosis of patients with advanced non small cell lung (NSCLC) cancer remains dismal. EpidermalPalabras claves:Autores:Carmen Elena Viada, García Verdecia B., González G., Lage Davila A., Luaces P.L.o., Montero E., Neninger Vinageras E., Popa X., Rodríguez P.C., Tania CrombetFuentes:scopusThe anti-CD6 antibody itolizumab provides clinical benefit without lymphopenia in rheumatoid arthritis patients: results from a 6-month, open-label Phase I clinical trial
ArticleAbstract: Itolizumab is a humanized anti-CD6 monoclonal antibody (mAb) that has previously shown encouraging rPalabras claves:CD6, Clinical trial, Itolizumab, Phase I, Rheumatoid ArthritisAutores:Aira L.E., Ávila Y., Barrese Y., Carmen Elena Viada, Gómez J.A., Hernández I.M., Hernández M.V., Hernández P., López A.M., Martínez J.P., Milera J.M., Molinero C., Montero E., Moreno E., Prada D.M., Reyes Y., Rodríguez P.C., Torres R.Fuentes:scopus